Bioequivalence of Sitagliptin Phosphate/Metformin Hydrochloride Tablets in Healthy Chinese Subjects
Condition: Healthy Subjects Interventions: Drug: Sitagliptin Phosphate/metformin Hydrochloride Tablets(JANUMET®,50mg/850mg); Drug: Sitagliptin Phosphate/metformin Hydrochloride Tablets (50mg/850mg) Sponsor: The Affiliated Hospital of Qingdao University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 7, 2021 Category: Research Source Type: clinical trials